miDiagnostics

TLDR

miDiagnostics is a Belgian medtech Company Building compact diagnostic equipment, having raised $31.5M in a Series D round in December 2024, with Alychlo among its investors.

Overview

miDiagnostics develops miniaturized diagnostic devices that bring laboratory-quality testing closer to the patient. The compact form factor targets point-of-care settings where traditional lab infrastructure is unavailable or where speed of results is critical.

The $31.5M Series D, closed in December 2024, funds scaling of manufacturing and commercial operations. Alychlo, the investment vehicle of Marc Coucke, is among the backers, adding a prominent Belgian investor to the cap table.

The Series D stage indicates the company has moved past early clinical validation and is focused on commercial expansion.

Funding History

• Series D: $31.5M (December 2024)